Key result
Mobile health interventions improved medication adherence in patients with heart failure and reduced readmission rates and mortality.
Why the study?
The study was designed to systematically evaluate the effectiveness of mobile health interventions on medication adherence in patients with heart failure.
Do mobile health (mHealth) interventions improve medication adherence and clinical outcomes in patients with heart failure?
Meta-Analysis (n=2,534)
Do mobile health (mHealth) interventions improve medication adherence and clinical outcomes in patients with heart failure?
Mobile health interventions are effective in improving medication adherence and reducing both readmission rates and mortality in patients with heart failure.
Answers are grounded in this paper and cite their sources.
Supports incorporating mobile health into heart failure care; reinforces evidence for digital adherence tools in chronic disease management.
AIMS: To systematically evaluate the effectiveness of mobile health (mHealth) interventions on medication adherence in patients with heart failure. METHODS: The literature search was conducted in PubMed, Web of Science, the Cochrane Library databases, Embase, China National Knowledge Infrastructure (CNKI), Wanfang Database and China Scientific Journal Database (VIP). The retrieval period was from the establishment of the database to May 2023. The included studies were trials to explore the effectiveness of mHealth interventions on medication adherence in patients with heart failure. Cochrane collaboration's tool was used for assessing risk of bias in randomized controlled trials. Stata 17.0 software was used to conduct data analysis. Continuous data were expressed as standard mean differences, and dichotomous data were expressed as relative risks with 95% confidence intervals (CIs). RESULTS: A total of 13 studies and 2534 participants were included. One study was rated as Grade A, and the other 12 studies were Grade B. The results of meta-analysis indicate that mHealth interventions are effective in improving medication adherence [relative risk (RR) = 1.26, 95% CI 1.10-1.44, P < 0.05 and standard mean difference = 0.80, 95% CI 0.44-1.15, P < 0.05], and reducing readmission rates (RR = 0.63, 95% CI 0.53-0.76, P < 0.05) and mortality (RR = 0.63, 95% CI 0.43-0.94, P < 0.05) of patients with heart failure. CONCLUSION: mHealth interventions are beneficial to improve medication adherence in patients with heart failure, and could effectively reduce the readmission rates and mortality of patients in the studies. There is a need to continuously improve the professional abilities of intervention personnel, carry out teamwork, and extend intervention and follow-up time. Convenient, fast and low-cost mobile medical devices should be adopted to reduce the cost of medical treatment. Scientific and reasonable intervention content will be formulated according to evidence-based guidelines and theoretical basis to enhance patients' ability at self-management and understanding of heart failure knowledge.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) conducted a meta-analysis in heart failure (n=2,534). Mobile health (mHealth) interventions was evaluated on Medication adherence (RR 1.26, 95% CI 1.10-1.44, p=< 0.05). Mobile health interventions improved medication adherence in patients with heart failure and reduced readmission rates and mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: